Monday, April 07, 2014 1:36:43 PM
I note with interest that the highly touted Pfiser breast cancer drug, while keeping the cancer at bay for 20
months vs the best out there 10 months, did little to affect overall survival.
Now I know this is asking a lot, but if Enmd has good news on the triple negative trial, especially
relative to overall survival, could they possibly forego keeping it as secret as possible for as long
as possible!
Broadway
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM